Table 5.
Indication for esophagogastroduodenoscopy, which led to gastric cancer diagnosis.
| Parameter | AIG | No AIG | p-value | OR (95% CI) |
|---|---|---|---|---|
| N | 28 | 56 | ||
| Pernicious anemia (%) | 10 (36) | 0 (0) | – | 290 (7.2–116.4) |
| Upper abdominal pain (%) | 5 (18) | 24 (43) | 0.023 | 3.5 (1.1–10.4) |
| Asthenia, fatigue, weakness (%) | 5 (18) | 16 (29) | 0.285 | 1.8 (0.6–5.7) |
| Feeling of increased abdominal fullness (%) | 5 (18) | 14 (25) | 0.461 | 1.5 (0.5–4.8) |
| Nausea (%) | 5 (18) | 8 (14) | 0.670 | 1.3 (0.4–4.4) |
| Loss of weight (%) | 4 (14) | 20 (36) | 0.040 | 3.3 (1.0–11.0) |
| Lack of appetite (%) | 4 (14) | 14 (25) | 0.259 | 0.5 (0.1–1.7) |
| Vomiting (%) | 4 (14) | 8 (14) | 1.000 | 1.0 (0.3–3.7) |
| Dysphagia (%) | 3 (11) | 7 (13) | 0.812 | 0.8 (0.2–3.5) |
| Incidental finding (%) | 2 (7) | 6 (11) | 0.599 | 0.6 (0.1–3.4) |
| Melena (%) | 2 (7) | 6 (11) | 0.599 | 0.6 (0.1–3.4) |
| Heartburn (%) | 2 (7) | 4 (7) | 1.000 | 0.8 (0.1–4.4) |
| Backpain (%) | 0 (0) | 5 (9) | – | 0.2 (0.0–1.4) |
| Lower abdominal pain (%) | 0 (0) | 4 (7) | – | 0.2 (0.0–1.8) |
AIG: autoimmune gastritis; CI: confidence interval; OR: odds ratio.
p-values ≤ 0.05 (bold) are statistically significant (X2 test).